Insights & Resources

Weaver’s Transaction Advisory Services team highlights a recent success story, guiding a client through an investment in a fast-casual restaurant.

Explore why profitable hospitals command higher valuations and how variability in transaction databases impacts fair market value.

Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.

Learn about the risks of profit tunneling in nursing homes and why fair market value transactions help ensure compliance and financial integrity.

Explore ASC 805’s role in bringing clarity to business combinations — from fair value measurements to goodwill and beyond.

Get ahead of the curve by looking back at emerging trends in 2024 that are likely to impact health care valuation in 2025 and beyond. Download Weaver Insights now.

The shortage of key health care providers is impacting health care services. We explore factors driving demand and how this affects valuations.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

Rising physician compensation and growing financial losses are putting health systems under pressure. Explore the 2024 trends and valuation insights.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Due diligence is a crucial step in any merger and acquisition process. This can be especially challenging for Software-as-a-Service (SaaS) companies.

With an increasing demand for lithium across the energy sector, oilfields may find a common biproduct may hold the key to future growth.